The number of people with susceptibility test result for rifampicin in New Caledonia
New Caledonia: The number of people with susceptibility test result for rifampicin was 15 in 2021. ▼ Falling
Latest (2021)
15
Change on year
down 37.5%
World rank
135th
of 155 countries
All-time high
25
in 2017
All-time low
15
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in New Caledonia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in New Caledonia is 15, measured in 2021. That is the lowest value across all 5 years on record.
The figure is down 37.5% on the previous year and down 40.0% over five years.
New Caledonia ranks 135th of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in New Caledonia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 25 | — |
| 2018 | 23 | -8.0% |
| 2019 | 16 | -30.4% |
| 2020 | 24 | +50.0% |
| 2021 | 15 | -37.5% |
New Caledonia compared with similar countries
- New Caledonia's 15 is below the median for high income countries, which is 142, 11% of the median. (61 countries reporting)
- New Caledonia's 15 is below the median for East Asia & Pacific, which is 185, 8% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 21.33 | 16 | 25 | 3 |
| 2020s | 19.5 | 15 | 24 | 2 |
Countries ranked near New Caledonia
More health data for New Caledonia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3381 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,128 deaths per 1,000 people (2090)
- Number of infants who die before age 1 6 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -0.4956 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.034 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3761 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2024)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in New Caledonia?
- The number of people with susceptibility test result for rifampicin in New Caledonia was 15 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in New Caledonia?
- The highest recorded value was 25 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in New Caledonia?
- The lowest recorded value was 15 in 2021.
- How does New Caledonia rank for the number of people with susceptibility test result for rifampicin?
- New Caledonia ranks 135th out of 155 countries with data for 2021.
- Where does this New Caledonia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).